Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 179B is a poorly characterized, predicted 4-pass transmembrane protein that belongs to the TMEM179 family. It encodes a human protein of 219 amino acids, with no conserved Pfam domain or established molecular function. TMEM179B and its family member TMEM179 share approximately 38% sequence identity but neither is functionally annotated beyond their putative transmembrane domain structure[2][5]. No proven involvement in receptor, transporter, or enzyme activity exists. The broader family of four-transmembrane proteins (4TM) is structurally related to miscellaneous transmembrane proteins that may play roles in cell communication, adhesion, or scaffolding functions, but TMEM179B is not classified in any specific subclass, nor does it have documented disease linkage. Tissue expression or co-expression data are not sufficiently detailed to infer functionality. Currently, TMEM179B represents an uncharacterized membrane protein awaiting further biological and pharmacological study[2][5].
Not applicable. No mechanism of action reported, as no drugs target this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 179B (TMEM179B).